作者: Vittorina Zagonel , Umberto Tirelli , Diego Serraino , Giovanni Lo Re , Maria Carmela Merola
DOI: 10.2165/00002512-199404010-00004
关键词:
摘要: Elderly patients with lung cancer have not benefited from the therapeutic improvements obtained during 1980s younger adults. Potentially operable non-small-cell cancers are more common in elderly patients, who likely to localized disease at diagnosis. Even so, rarely treated surgery. Radiotherapy remains most frequently adopted tool treat this age group. Epipodophyllotoxin derivatives constitute best option for chemotherapy of small-cell cancer. When used as single agent regimens, these drugs show same overall response rate combination chemotherapy, but reduced toxicity. Haematopoietic growth factors reduce bone marrow damage following cytotoxic and may be a promising patients. Special attention should given increasing number enrolled phase I II studies investigate new agents treatment tumour.